Insider · CIK 0001577034

Gould Robert J

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001577034

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2026-02-02	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$10.72	−$161K	454,864
2026-01-02	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$11.87	−$178K	469,864
2026-01-02	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$10.87	−$163K	469,864
2025-11-19	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$11.03	−$165K	484,864
2025-06-26	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000
2024-06-17	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-03	Turnstone Biologics Corp.Stock Option (Right to Buy)A Award	Director	AAward	+12.8K sh	—	—	12,770
2023-06-27	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-01-13	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−6,766 sh	$15.00	−$101K	499,864
2022-06-27	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2022-06-07	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−71.4K sh	$8.09	−$578K	506,630
2022-06-07	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+71.4K sh	$7.84	+$560K	578,065
2022-06-07	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−71.4K sh	—	—	86,523
2022-06-06	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−24.4K sh	$8.10	−$198K	506,630
2022-06-06	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24.4K sh	$7.84	+$191K	531,012
2022-06-06	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.4K sh	—	—	157,958
2022-06-03	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25.6K sh	$7.84	+$200K	532,181
2022-06-03	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−25.6K sh	$7.95	−$203K	506,630
2022-06-03	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−25.6K sh	—	—	182,340
2022-06-02	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−16.7K sh	—	—	207,891
2022-06-02	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.7K sh	$7.84	+$131K	523,319
2022-06-02	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−16.7K sh	$7.92	−$132K	506,630
2022-04-07	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,631 sh	$7.84	+$44.1K	512,261
2022-04-07	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,631 sh	—	—	224,580
2022-04-07	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−5,631 sh	$24.02	−$135K	506,630
2022-04-05	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+52.6K sh	$7.84	+$412K	559,182
2022-04-05	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−52.6K sh	$24.26	−$1.27M	506,630
2022-04-05	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−52.6K sh	—	—	230,211
2022-04-04	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−7,235 sh	$24.02	−$174K	506,630
2022-04-04	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,235 sh	$7.84	+$56.7K	513,865
2022-04-04	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,235 sh	—	—	282,763
2022-04-01	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−34.5K sh	$24.03	−$828K	506,630
2022-04-01	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−34.5K sh	—	—	289,998
2022-04-01	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.5K sh	$7.84	+$270K	541,094
2021-03-16	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−789 sh	$12.43	−$9,805.613	506,630
2021-03-15	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−9,211 sh	$12.13	−$112K	507,419
2021-02-16	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−1,673 sh	$14.56	−$24.4K	516,630
2021-02-16	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−6,542 sh	$14.19	−$92.8K	518,303
2021-02-02	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+269K sh	—	—	269,390
2021-01-20	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$12.08	−$121K	524,845
2020-07-08	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$20.00	−$50K	534,845
2020-06-25	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−2,500 sh	$20.80	−$52K	537,345
2020-06-09	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−156 sh	$20.00	−$3,120	539,845
2020-06-05	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−3,433 sh	$20.17	−$69.3K	540,001
2020-06-04	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−1,300 sh	$20.04	−$26.1K	543,434
2020-06-03	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−1,500 sh	$20.13	−$30.2K	544,734
2020-06-02	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−2,797 sh	$20.00	−$55.9K	546,234
2020-06-01	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−5 sh	$20.00	−$100	549,031
2020-05-29	FULCFulcrum Therapeutics, Inc.S Sale	Director	SSale	−1,390 sh	$20.08	−$27.9K	549,036

Recent filings

Accepted (ET)
Jul 24
Gould Robert J0001193125-26-294697
SEC(opens sec.gov)
Feb 44
Gould Robert J0001193125-26-037573
SEC(opens sec.gov)
Feb 44/A
Gould Robert J0001193125-26-037606
SEC(opens sec.gov)
Jan 64
Gould Robert J0001193125-26-004572
SEC(opens sec.gov)
Nov 214
Gould Robert J0001193125-25-291392
SEC(opens sec.gov)
Jun 304
Gould Robert J0000950170-25-091578
SEC(opens sec.gov)
Jul 24
Gould Robert J0001415889-24-018926
SEC(opens sec.gov)
Jun 184
Gould Robert J0000950170-24-074888
SEC(opens sec.gov)
Jun 294
Gould Robert J0000950170-23-030753
SEC(opens sec.gov)
Jan 134
Gould Robert J0000899243-23-001803
SEC(opens sec.gov)
Jun 294
Gould Robert J0000899243-22-024527
SEC(opens sec.gov)
Jun 84
Gould Robert J0000899243-22-021530
SEC(opens sec.gov)
Jun 64
Gould Robert J0000899243-22-021250
SEC(opens sec.gov)

Companies

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139